Cerebrolysin
Enhances cognitive function, promotes growth and repair of neurons, supports recovery from brain injury, reduces neuroinflammation, boosts brain resilience and longevity.
Research Benefits
Available at
Pantheon Peptides
Affiliate disclosure: PeptidesMaxxing earns a commission at no cost to you.
What is Cerebrolysin?
Cerebrolysin is a standardized mixture of neurotrophic peptide fragments derived from porcine brain tissue — created by enzymatic hydrolysis that breaks larger brain proteins into small, bioactive fragments. It is used clinically in over 40 countries for stroke recovery, traumatic brain injury, Alzheimer's disease, and vascular dementia, with clinical data spanning more than 40 years.
Unlike single-compound peptides, Cerebrolysin is a complex mixture of peptides and amino acids that collectively mimic the effects of endogenous neurotrophic factors (BDNF, NGF, CNTF, GDNF) — the growth factors that support neuron survival, plasticity, and repair.
Mechanism of Action
Neurotrophic Factor Mimicry
Cerebrolysin's peptide components mimic and augment the effects of multiple endogenous neurotrophic factors simultaneously. Unlike exogenous BDNF or NGF administration (which cannot cross the blood-brain barrier), Cerebrolysin's small fragments penetrate the CNS and produce neurotrophic effects at the neuronal level.
Neuroprotection
Research demonstrates Cerebrolysin inhibits caspase-mediated apoptosis, reduces oxidative damage in neural tissue, and modulates excitotoxic glutamate signaling — providing comprehensive neuroprotection in models of injury and neurodegeneration.
Neuroplasticity Enhancement
Cerebrolysin promotes synaptogenesis, axonal sprouting, and dendritic branching — structural manifestations of neuroplasticity that underlie learning, memory, and functional recovery after injury.
Neuroinflammation Reduction
The compound modulates microglia function and reduces neuroinflammatory cytokine production — addressing the chronic neuroinflammation that contributes to progressive neurodegeneration.
Key Research Findings
Meta-analyses of Cerebrolysin clinical trials in stroke recovery show significant improvements in neurological outcomes and activities of daily living. Alzheimer's research has demonstrated improvements in cognitive test scores and delay of disease progression. The safety profile across decades of clinical use in multiple countries is well-established.
*For research use only. Not for human consumption.*
Research Use Only: This product is for laboratory research purposes only. Not intended for human consumption. Not approved by the FDA for any therapeutic use. Consult a qualified physician before any use.
Ready to order Cerebrolysin?
Research-grade purity from Pantheon Peptides.
Related Research
You Might Also Need
Reduces anxiety and mood stabilization, Enhances overall cognitive function, Neuroprotection and neuroregeneration, Reduces mental fatigue, Improves Sleep, Boosts Immune Function.
Advanced cognitive support for Alzheimer's, Dementia, Stroke and Brain Injury.